X4 PHARMACEUTICALS, INC Number of Reporting Units
X4 PHARMACEUTICALS, INC (XFOR) reported Number of Reporting Units of 1 reporting_unit for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-26.
Financial Statements › Notes
us-gaap:NumberOfReportingUnits · last filed 2025-03-26
- X4 PHARMACEUTICALS, INC number of reporting units for the quarter ending 2020-03-31 was 1.00 reporting_unit.
- X4 PHARMACEUTICALS, INC number of reporting units for fiscal 2024 was 1.00 reporting_unit, a 0.00% change from fiscal 2023.
- X4 PHARMACEUTICALS, INC number of reporting units for fiscal 2023 was 1.00 reporting_unit, a 0.00% change from fiscal 2022.
- X4 PHARMACEUTICALS, INC number of reporting units for fiscal 2022 was 1.00 reporting_unit, a 0.00% change from fiscal 2021.
- X4 PHARMACEUTICALS, INC number of reporting units for fiscal 2021 was 1.00 reporting_unit, a 0.00% change from fiscal 2020.
| Period end | Number of Reporting Units 3 month | Number of Reporting Units 9 month | Number of Reporting Units 12 month |
|---|---|---|---|
| 2024-12-31 | 1.00 reporting_unit 10-K · filed 2025-03-26 | ||
| 2023-12-31 | 1.00 reporting_unit 10-K · filed 2024-03-21 | ||
| 2022-12-31 | 1.00 reporting_unit 10-K · filed 2023-03-21 | ||
| 2021-12-31 | 1.00 reporting_unit 10-K · filed 2022-03-17 | ||
| 2020-12-31 | 1.00 reporting_unit 10-K · filed 2021-03-19 | ||
| 2020-03-31 | 1.00 reporting_unit 10-Q · filed 2020-05-07 | ||
| 2019-12-31 | 1.00 reporting_unit 10-K · filed 2020-03-12 | ||
| 2019-09-30 | 1.00 reporting_unit 10-Q · filed 2019-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| SAB Biotherapeutics, Inc. (SABS) | United States | $0.306B | -25.49 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |
| Liminatus Pharma, Inc. (LIMN) | United States | $0.282B | |
| FATE THERAPEUTICS INC (FATE) | United States | $0.280B | -2.51 |
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |